SOLIGENIX, INC. Foreign Currency Transaction Gain (Loss), Realized
SOLIGENIX, INC. (SNGX) reported Foreign Currency Transaction Gain (Loss), Realized of $1.59 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-21.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2025-03-21
- SOLIGENIX, INC. foreign currency transaction gain (loss), realized for the quarter ending 2024-12-31 was -$666.00, a 156.78% decline year-over-year.
- SOLIGENIX, INC. foreign currency transaction gain (loss), realized for the quarter ending 2024-09-30 was $575.00.
- SOLIGENIX, INC. foreign currency transaction gain (loss), realized for the quarter ending 2024-06-30 was $473.00, a 87.29% decline year-over-year.
- SOLIGENIX, INC. foreign currency transaction gain (loss), realized for the quarter ending 2024-03-31 was $1.21K.
- SOLIGENIX, INC. foreign currency transaction gain (loss), realized for fiscal 2024 was $1.59K, a 7.28% increase from fiscal 2023.
- SOLIGENIX, INC. foreign currency transaction gain (loss), realized for fiscal 2023 was $1.48K, a 95.15% decline from fiscal 2022.
- SOLIGENIX, INC. foreign currency transaction gain (loss), realized for fiscal 2022 was $30.55K.
- SOLIGENIX, INC. foreign currency transaction gain (loss), realized for fiscal 2021 was -$39.36K.
| Period end | Foreign Currency Transaction Gain (Loss), Realized 3 month | Foreign Currency Transaction Gain (Loss), Realized 3 month as first filed | Foreign Currency Transaction Gain (Loss), Realized 6 month | Foreign Currency Transaction Gain (Loss), Realized 6 month as first filed | Foreign Currency Transaction Gain (Loss), Realized 9 month | Foreign Currency Transaction Gain (Loss), Realized 9 month as first filed | Foreign Currency Transaction Gain (Loss), Realized 12 month | Foreign Currency Transaction Gain (Loss), Realized 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -$666.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$91.00 derived: sum of 2 quarters · filed 2025-03-21 | $382.00 derived: sum of 3 quarters · filed 2025-03-21 | $1.59K 10-K · filed 2025-03-21 | ||||
| 2024-09-30 | $575.00 10-Q · filed 2024-11-08 | $1.05K derived: sum of 2 quarters · filed 2024-11-08 | $2.26K 10-Q · filed 2024-11-08 | $3.43K derived: sum of 4 quarters · filed 2025-03-21 | ||||
| 2024-06-30 | $473.00 10-Q · filed 2024-08-09 | $1.68K 10-Q · filed 2024-08-09 | $2.85K derived: sum of 3 quarters · filed 2025-03-21 | -$191.00 derived: sum of 4 quarters · filed 2025-03-21 | ||||
| 2024-03-31 | $1.21K 10-Q · filed 2024-05-10 | $2.38K derived: sum of 2 quarters · filed 2025-03-21 | -$664.00 derived: sum of 3 quarters · filed 2025-03-21 | $3.06K derived: sum of 4 quarters · filed 2025-03-21 | ||||
| 2023-12-31 | $1.17K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$1.87K derived: sum of 2 quarters · filed 2025-03-21 | $1.85K derived: sum of 3 quarters · filed 2025-03-21 | $1.48K 10-K · filed 2025-03-21 | -$1.48K 10-K · filed 2024-03-15 | |||
| 2023-09-30 | -$3.05K 10-Q · filed 2024-11-08 | $676.00 derived: sum of 2 quarters · filed 2024-11-08 | $310.00 10-Q · filed 2024-11-08 | $56.87K derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | $3.72K 10-Q · filed 2024-08-09 | $3.36K 10-Q · filed 2024-08-09 | $59.91K derived: sum of 3 quarters · filed 2024-08-09 | $47.30K derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | -$366.00 10-Q · filed 2024-05-10 | $366.00 10-Q · filed 2023-05-15 | $56.19K derived: sum of 2 quarters · filed 2024-05-10 | $43.58K derived: sum of 3 quarters · filed 2024-05-10 | $138.48K derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | $56.55K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $43.94K derived: sum of 2 quarters · filed 2024-03-15 | $138.84K derived: sum of 3 quarters · filed 2024-03-15 | $30.55K 10-K · filed 2024-03-15 | -$30.55K 10-K · filed 2023-03-31 | |||
| 2022-09-30 | -$12.61K 10-Q · filed 2023-11-13 | $82.29K derived: sum of 2 quarters · filed 2023-11-13 | -$26.01K 10-Q · filed 2023-11-13 | $173.60K derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $94.90K 10-Q · filed 2023-08-21 | -$13.39K 10-Q · filed 2023-08-21 | $186.22K derived: sum of 3 quarters · filed 2023-08-21 | $119.25K derived: sum of 4 quarters · filed 2023-08-21 | ||||
| 2022-03-31 | $108.29K 10-Q · filed 2023-05-15 | -$108.29K 10-Q · filed 2022-05-13 | $91.32K derived: sum of 2 quarters · filed 2023-05-15 | $24.35K derived: sum of 3 quarters · filed 2023-05-15 | $41.68K derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | -$16.98K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$83.94K derived: sum of 2 quarters · filed 2023-03-31 | -$66.61K derived: sum of 3 quarters · filed 2023-03-31 | -$39.36K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | -$66.97K 10-Q · filed 2022-11-10 | $66.97K 10-Q · filed 2021-11-12 | -$49.64K derived: sum of 2 quarters · filed 2022-11-10 | -$22.38K 10-Q · filed 2022-11-10 | $22.38K 10-Q · filed 2021-11-12 | -$80.23K derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $17.33K 10-Q · filed 2022-08-12 | $44.58K 10-Q · filed 2022-08-12 | -$13.27K derived: sum of 3 quarters · filed 2022-08-12 | -$5.62K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $27.25K 10-Q · filed 2022-05-13 | -$30.60K derived: sum of 2 quarters · filed 2022-05-13 | -$22.95K derived: sum of 3 quarters · filed 2022-05-13 | -$26.53K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -$57.85K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$50.20K derived: sum of 2 quarters · filed 2022-03-29 | -$53.79K derived: sum of 3 quarters · filed 2022-03-29 | -$23.39K 10-K · filed 2022-03-29 | ||||
| 2020-09-30 | $7.65K 10-Q · filed 2021-11-12 | -$7.65K 10-Q · filed 2020-11-12 | $4.06K derived: sum of 2 quarters · filed 2021-11-12 | $34.47K 10-Q · filed 2021-11-12 | -$34.47K 10-Q · filed 2020-11-12 | -$38.46K derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | -$3.58K 10-Q · filed 2021-08-13 | $26.82K 10-Q · filed 2021-08-13 | -$26.82K 10-Q · filed 2020-08-14 | -$46.10K derived: sum of 3 quarters · filed 2021-08-13 | -$37.29K derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | -$23.23K 10-Q · filed 2021-05-18 | $23.23K 10-Q · filed 2020-05-15 | -$42.52K derived: sum of 2 quarters · filed 2021-05-18 | -$33.71K derived: sum of 3 quarters · filed 2021-05-18 | -$32.19K derived: sum of 4 quarters · filed 2021-05-18 | |||
| 2019-12-31 | -$19.29K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$10.48K derived: sum of 2 quarters · filed 2021-03-30 | -$8.96K derived: sum of 3 quarters · filed 2021-03-30 | -$7.81K 10-K · filed 2021-03-30 | $7.81K 10-K · filed 2020-03-30 | |||
| 2019-09-30 | $8.81K 10-Q · filed 2020-11-12 | $10.33K derived: sum of 2 quarters · filed 2020-11-12 | $11.48K 10-Q · filed 2020-11-12 | |||||
| 2019-06-30 | $1.52K 10-Q · filed 2020-08-14 | $6.53K 10-Q · filed 2020-08-14 | ||||||
| 2019-03-31 | $5.01K 10-Q · filed 2020-05-15 | |||||||
| 2018-12-31 | $437.00 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |